Abstract
Corticotropin-releasing hormone (CRH) exhibits anti-inflammatory properties independent of its effect on adrenal function. We investigated the safety and effect of CRH in nocturnal asthma, a disease where inflammation is prominent. Five subjects underwent an overnight infusion of placebo on the first night, CRH at a 2.5 μg/kg/hr on the second night, and three subjects received CRH at 4.0 μg/kg/hr on the third night. A significant improvement occurred in overnight change in forced expiratory volume at 1 sec. % (ΔFEV1) with CRH (+17.4 ± 9.1%) as opposed to placebo (-25.9 ± 7.1%), p = 0.024. CRH was well tolerated. Further research with CRH may clarify the pathophysiology of nocturnal asthma.
Original language | English (US) |
---|---|
Pages (from-to) | 261-265 |
Number of pages | 5 |
Journal | Journal of Asthma |
Volume | 35 |
Issue number | 3 |
DOIs | |
State | Published - 1998 |
Keywords
- Corticotropin-releasing hormone
- Inflammation
- Nocturnal asthma
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Immunology and Allergy
- Pulmonary and Respiratory Medicine